Establishment and characterization of clinically relevant models of ependymoma: a true challenge for targeted therapy

A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo

(2010) L. Yu et al.   NEURO-ONCOLOGY

Initial testing (stage 1) of the Akt inhibitor GSK690693 by the pediatric preclinical testing program

(2010) Hernan Carol et al.   PEDIATRIC BLOOD & CANCER

Classification and controversies in pathology of ependymomas

(2009) Catherine Godfraind   CHILDS NERVOUS SYSTEM

New chemotherapy strategies and biological agents in the treatment of childhood ependymoma

(2009) Karen D. Wright et al.   CHILDS NERVOUS SYSTEM

OUTCOME PREDICTORS FOR INTRACRANIAL EPENDYMOMA RADIOSURGERY

(2009) Hideyuki Kano et al.   NEUROSURGERY

Targeted Inhibition of Cyclic AMP Phosphodiesterase-4 Promotes Brain Tumor Regression

(2008) P. Goldhoff et al.   CLINICAL CANCER RESEARCH

Cytokine and Growth Factor Responses After Radiotherapy for Localized Ependymoma

(2008) Thomas E. Merchant et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Childhood Brain Tumors: Accomplishments and Ongoing Challenges

(2008) Roger J. Packer   JOURNAL OF CHILD NEUROLOGY

Biological background of pediatric medulloblastoma and ependymoma: A review from a translational research perspective

(2008) Judith M. de Bont et al.   NEURO-ONCOLOGY

High-dose Chemotherapy and Adoptive Immunotherapy in the Treatment of Recurrent Pediatric Brain Tumors

(2008) E. Peres et al.   NEUROPEDIATRICS

Both location and age predict survival in ependymoma: A SEER study

(2008) Courtney S. McGuire et al.   PEDIATRIC BLOOD & CANCER